Devices › Catheter, septostomy
Device brand name · Catheter septostomy
VersaCross Access Solution: medical device reports filed with FDA
418 reports name it, 2022–2026. Manufacturer given most often on reports: Baylis Medical. Product code DXF.
- 418
- device reports naming the brand
- 0% of all MAUDE reports · about 109 a year
- 144
- reports, 12 months to August 2026
- 91 in the 12 months before
- 29.7%
- classified as malfunction
- 30.7% across the product code
- 7.9%
- classified as death, as reported
- 33 reports · not verified by FDA
FDA's MAUDE database holds 418 reports that name the brand "VersaCross Access Solution" (catheter septostomy), received between September 2022 and August 2026; the manufacturer given most often on reports is Baylis Medical. Spellings of one product vary from report to report.
144 reports arrived in the 12 months to August 2026, up 58% from 91 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (62.4%), malfunction (29.7%) and death (7.9%); across all catheter, septostomy reports (product code DXF) death is recorded in 4.9% and malfunction in 30.7%. Event type is the reporter's classification of the report, not a verified outcome.
The device problems coded most often are difficult to advance (13.2%), material integrity problem (7.4%) and positioning problem (6.9%). The patient problems coded most often are pericardial effusion, low blood pressure/ hypotension and cardiac perforation. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Reports by month, five years
Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.
By year received
Event type and report source
Event type, as classified on the report
Who filed the report
Grey bar: all 2,205 reports carrying product code DXF. Event type is the filer's classification and is not verified by FDA.
Device problems coded
| Device problem (FDA code) | Reports | Share | Share across product code |
|---|---|---|---|
| Difficult to advance | 55 | 13.2% | 11.4% |
| Material integrity problema problem with the device material | 31 | 7.4% | 8.4% |
| Positioning problem | 29 | 6.9% | 4.4% |
| Failure to advance | 25 | 6% | 10.2% |
| Display or visual feedback problem | 24 | 5.7% | 4.9% |
| Physical resistance/sticking | 23 | 5.5% | 3.3% |
| Material deformation | 18 | 4.3% | 3.6% |
| Device-device incompatibility | 17 | 4.1% | 1.4% |
| Off-label use | 15 | 3.6% | 1.9% |
| Defective devicethe device was defective | 11 | 2.6% | 1% |
| Material frayed | 7 | 1.7% | 0.8% |
| Nonstandard device | 7 | 1.7% | 1.5% |
| Deformation due to compressive stress | 6 | 1.4% | 1.1% |
| Device dislodged or dislocated | 6 | 1.4% | 1% |
| Device displays incorrect message | 4 | 1% | 0.4% |
| Mechanical problema mechanical problem | 4 | 1% | 0.1% |
| Air/gas in device | 3 | 0.7% | 0% |
| Device sensing problem | 3 | 0.7% | 2.5% |
| Difficult to removethe device was hard to remove | 3 | 0.7% | 1.4% |
| Leak/splashthe device leaked | 3 | 0.7% | 0.2% |
FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.
Patient problems coded
| Patient problem (FDA code) | Reports | Share |
|---|---|---|
| Pericardial effusionfluid around the heart | 212 | 50.7% |
| Low blood pressure/ hypotension | 114 | 27.3% |
| Cardiac perforation | 81 | 19.4% |
| Cardiac tamponade | 80 | 19.1% |
| Cardiac arrestthe heart stopped | 22 | 5.3% |
| Thrombosis/thrombus | 21 | 5% |
| Air embolism | 14 | 3.3% |
| Hemorrhage/blood loss/bleeding | 13 | 3.1% |
| Non specific ekg/ECG changes | 12 | 2.9% |
| Perforation of vessels | 12 | 2.9% |
| Tachycardiafast heart rate | 10 | 2.4% |
| Dyspneashortness of breath | 9 | 2.2% |
| Perforation | 9 | 2.2% |
| Hematomaa collection of blood under the skin or in tissue | 7 | 1.7% |
| High blood pressure/ hypertension | 6 | 1.4% |
Patient problem codes are present mainly in reports filed since 2019 and are often blank.
In context
| Measure | VersaCross Access Solution | Product code DXF | All MAUDE reports |
|---|---|---|---|
| Reports | 418 | 2,205 | 26,136,888 |
| Share of that pool | — | 19% | 0% |
| Classified as death, per 1,000 reports | 79 | 49 | 9 |
| Classified as injury | 62.4% | 64.2% | 36.2% |
| Classified as malfunction | 29.7% | 30.7% | 62.3% |
| Filed by the manufacturer | 98.8% | 96.1% | 94.9% |
Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Other brands with product code DXF
| Brand | Reports | Latest 12 months | Classified as death |
|---|---|---|---|
| VersaCross Connect LAAC Access Solution | 1,111 | 371 | 6% |
| VersaCross Connect Access Solution for FARADRIVE | 569 | 280 | 1.9% |
| NRG Transseptal Needle | 263 | 24 | 4.2% |
| RF Needle | 180 | 64 | 0.6% |
Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."
Questions about VersaCross Access Solution reports
How many FDA reports name VersaCross Access Solution?
418 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 144 in the latest 12 months.
What kinds of events are reported?
injury (62.4%), malfunction (29.7%) and death (7.9%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.
What device problems are coded?
difficult to advance (13.2%), material integrity problem (7.4%), positioning problem (6.9%), failure to advance (6%) and display or visual feedback problem (5.7%). These are FDA's device problem codes as entered on the report.
Who files these reports?
manufacturer reports (98.8%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.
Do these reports show that VersaCross Access Solution was at fault?
No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."
How do I report a problem with a medical device?
Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.
Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.